Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies (Q35212678)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
scientific article

    Statements

    Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit